Denmark· DK-28107304824
Teizeild
A teplizumab product containing teplizumab, registered in Denmark by Sanofi Winthrop Industrie. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Teplizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC A10XX01 (teplizumab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Teplizumab · ATC A10XX01
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Teplizumab
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Denmark (DK)
- ATC code
- A10XX01
- ATC class
- Teplizumab
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107304824
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10XX01
Teplizumab, as other registers publish it.
- NorwayTeizeildSanofi Winthrop Industrie
- FinlandTeizeildSanofi Winthrop Industrie
- IcelandTeizeildSanofi Winthrop Industrie
- PolandTeizeildSanofi Winthrop Industrie
- CzechiaTEIZEILDSanofi Winthrop Industrie, Gentilly
- CzechiaTEIZEILDSanofi Winthrop Industrie, Gentilly
- CzechiaTEIZEILDSanofi Winthrop Industrie, Gentilly
- FranceTEIZEILD 1 mg/1 mL, solution à diluer pour perfusionSANOFI WINTHROP INDUSTRIE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c803b1b2-e65a-4d93-9123-c51607c92a48 GET /v1/drugs/c803b1b2-e65a-4d93-9123-c51607c92a48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "1 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28107304824",
"substance": "Teplizumab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "46030"
}See everything about teplizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.